Open AccessRadiochemotherapy in Anal Cancer: cCR, clinical outcomes and quality of life using two different treatment schedules
Author(s) -
Sara Di Santo,
Marianna Trignani,
Matteo Neri,
Angelo Milano,
Paolo Innocenti,
Maria Taraborrelli,
Antonietta Augurio,
A. Vinciguerra,
M. Di Tommaso,
Lucia Anna Ursini,
Angelo Di Pilla,
Marta Di Nicola,
Domenico Genovesi
Publication year - 2015
Publication title -
reports of practical oncology and radiotherapy
Language(s) - English
Resource type - Journals
eISSN - 2083-4640
pISSN - 1507-1367
DOI - 10.1016/j.rpor.2014.11.001
Subject(s) - medicine , anal cancer , fluorouracil , radiation therapy , clinical endpoint , cisplatin , oncology , log rank test , urology , quality of life (healthcare) , anal canal , clinical trial , survival analysis , cancer , chemotherapy , rectum , nursing
Main endpoint was a response rate to therapy; secondary endpoints were disease-free survival, overall survival, acute and late toxicities, specially in terms of anorectal and urinary continence.